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ORIGINAL ARTICLE EPIDEMIOLOGYCarriage of extended-spectrum β-lactamases in pig farmers is associated
with occurrence in pigsW. Dohmen1, M. J. M. Bonten2,3, M. E. H. Bos1, S. van Marm2, J. Scharringa2, J. A. Wagenaar4,5 and D. J. J. Heederik1
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University, Utrecht and 5) Central Veterinary Institute of Wageningen University and Research Centre, Lelystad, The NetherlandsAbstractLivestock may serve as a reservoir for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE). The objectives of this study
were to determine the prevalence of carriage with ESBL-PE in pig farmers, family members and employees, and its association with carriage in
pigs. Rectal swabs were taken from 2388 pigs (398 pooled samples) on 40 pig farms and faecal samples were obtained from 142 humans living
or working on 34 of these farms. Presence of ESBL-PE was determined by selective plating (agar). ESBL genes were analysed by PCR or
microarray analysis, and gene sequencing. Genotypes and plasmids were determined by multilocus sequence typing and PCR-based
replicon typing for selected isolates. ESBL genes were detected in Escherichia coli from eight humans (6%) (blaCTX-M-1, n = 6; blaTEM-52,
n = 1 and blaCTX-M-14, n = 1) on six farms. In 157 pig isolates (107 pooled samples) on 18 farms (45%) ESBL genes were detected
(blaCTX-M-1, n = 12; blaTEM-52, n = 6; and blaCTX-M-14, n = 3). Human and pig isolates within the same farm harboured similar ESBL gene
types and had identical sequence and plasmid types on two farms (e.g. E. coli ST-453, blaCTX-M-1, IncI1), suggesting clonal transmission.
For the remaining farms, sequence types, but not plasmid types, differed. Human ESBL carriage was associated with average number of
hours working on the farm per week (OR = 1.04, 95% CI 1.02–1.06) and presence of ESBLs in pigs (OR = 12.5, 95% CI 1.4–111.7).
Daily exposure to pigs carrying ESBL-PE is associated with ESBL carriage in humans.
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E-mail: W.dohmen@uu.nlIntroductionIn Europe, an elevated prevalence of blaCTX-M-1 has been re-
ported in poultry, cattle and pigs [1]. Extended-spectrum
β-lactamases (ESBLs) have been detected in meat samples
and transmission of ESBLs from livestock to humans through
the food chain has been suggested [2–5]. Antimicrobial-
resistant Enterobacteriaceae can also be transmitted from liveClinical Microbiology and Infection © 2015 European Society of Canimals to humans [6], but evidence for a role of direct
contact with livestock in human ESBL carriage is limited.
Transmission of blaCTX-M-1 harbouring IncI1 plasmids between
pigs and farmers was suggested in a molecular study on two
pig farms [7]. In another study, ESBL genes were detected in
broiler isolates from all 26 farms studied and in isolates from
six of 18 broiler farmers. Genetic similarities in genes and
plasmids among isolates from farmers and broilers were
documented on two farms [8]. ESBL carriage in farmers in
that study (33%) is high compared with hospital patients in the
southern part of the Netherlands (approximately 5%) [3]. It is
also high when compared with ESBL carriage in people living
in areas with high (3.6%) or low (6.7%) broiler densities in the
Netherlands [9].Clin Microbiol Infect 2015; 21: 917–923
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
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for human ESBL carriage. The objectives of this study were to
determine prevalence of carriage of ESBL-producing Enter-
obacteriaceae (ESBL-PE) in pig farmers, family members and
employees, and to determine the association between ESBL
carriage in humans and pigs.Materials and methodsStudy design
This is a cross-sectional analysis of samples that were derived in
a longitudinal study. On 40 multiplier pig farms (sows and
piglets present), with or without ﬁnishing pigs, faecal samples
from farmers, family members and employees were collected
using faeces cups (Minigrip®) and sent to the laboratory by mail
between March and October 2011. On each farm, rectal
samples from 60 pigs were collected by the farm veterinarian,
using sterile cotton-wool swabs (Cultiplast®) and sent refrig-
erated to the laboratory by courier. All animal age groups
present were sampled (sows, gilts, suckling piglets, weaning
piglets and ﬁnishing pigs). Rectal swabs were combined in ten
pools of six pigs. Each pool consisted of an age group in the
same pen. Participants ﬁlled out questionnaires on general
characteristics, farm activities, and intensity and duration of
animal contact. Questionnaires on farm characteristics were
ﬁlled out by veterinarians and farmers. The Medical Ethical
Committee of the University Medical Centre Utrecht approved
the study protocol (no. 10-471/K). All participants gave written
informed consent.
Laboratory analysis
Pooled swabs from pigs and faecal samples from humans were
analysed for the presence of ESBL-PE by selective plating.
Samples were suspended in 10 mL peptone water and incu-
bated overnight at 37°C. For screening of ESBL-PE, suspensions
were cultured on selective agar plates (Brilliance™ ESBL Agar,
Oxoid, Basingstoke, UK) and incubated overnight at 37°C.
When no growth was seen, plates were incubated for another
night at 37°C. Morphologically different colonies suspected of
ESBL production were cultured individually on a blood agar
plate (Oxoid) and incubated overnight at 37°C. In the case of
morphological uncertainty, an oxidase test was performed
before culturing. Bacterial species identiﬁcation of the isolates
was performed by matrix-assisted laser desorption/ionization/
time-of-ﬂight (Bruker, Billerica, MA, USA). For phenotypical
conﬁrmation of ESBL-PE, a 0.5 McFarland suspension was
inoculated on a Mueller–Hinton agar and a combination disc
test (Rosco, Taastrup, Denmark) including cefotaxime, cefo-
taxime+clavulanate, ceftazidime, ceftazidime+clavulanate,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcefepime and cefepime+clavulanate (Neo-Sensitabs™) was used
to conﬁrm the presence of ESBL-PE (EUCAST guidelines,
2012). Isolates were stored at –80°C before molecular analysis.
DNA was isolated using UltraClean® Microbial DNA Isola-
tion Kit (MO BIO Laboratories, Inc., West Carlsbad, CA, USA).
A blaCTX-M group-1-speciﬁc PCR was used to detect the
presence of the most prevalent ESBL gene group [10]. DNA
from blaCTX-M group-1-positive isolates was sequenced using
the same primers to determine the blaCTX-M group 1 gene type.
Isolates with a negative blaCTX-M group-1-speciﬁc PCR result
were analysed using ESBL microarray (Check-MDR CT101,
Checkpoints, Wageningen, the Netherlands) to detect blaTEM
group, blaSHV group or another blaCTX-M group (2,8,9,25). DNA
from ESBL microarray-positive isolates was sequenced with
group-speciﬁc primers to determine the exact gene type
[11,12]. DNA sequences were interpreted with Basic Local
Alignment Search Tool (National Center for Biotechnology
Information). For blaSHV and blaTEM groups, sequences were
also aligned with non-ESBL types (blaTEM-1, blaSHV-1) to deter-
mine the exact gene type based on single nucleotide
polymorphisms.
Genotyping and plasmid characterization were performed
for human and pig isolates with similar ESBL genes identiﬁed in
the same farm. For each human isolate, one pig isolate from the
same farm was selected. Genotypes and plasmid types were
determined by multilocus sequence typing (MLST) (MLST da-
tabases at UoW, Warwick, UK) and PCR-based replicon typing,
respectively [13]. The location of the ESBL genes on plasmids
was tested by transformation. Escherichia coli cells (ElectroMAX
DH10B™ cells, Life Technologies, Paisley, UK) were used as
recipient and Luria–Bertani agar plates containing cefotaxime
(1 mg/L) as selective agent. Whole genome sequencing was
available for eight human and pig isolates, plasmid types and
sequence types (ST) were reconstructed from these data [14].
Data analysis
Farms were classiﬁed as ESBL-positive if an ESBL gene was
detected in an isolate from at least one pooled pig sample.
Statistical analyses were performed using SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA). The association between ESBL
carriage in humans and pigs was calculated with logistic
regression analysis (PROC GENMOD) adjusted for clustering at
farm level. Presence of ESBLs in pigs, average number of hours
working per week, and potential confounders age, gender and
smoking were analysed univariately and selected for multivar-
iate analysis when the p-value was <0.2. Model selection was
performed by a backward procedure. Model ﬁt was checked
with the QIC-statistic (Quasi-likelihood under the Indepen-
dence model Criterion). The ﬁnal model retained variables
signiﬁcant at p  0.05.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 917–923
TABLE 1. General characteristics of the participants of the
study (n [ 142)
Human characteristics Frequency (%)
Gender
Male 85 (60)
Female 57 (40)
Category
Farmer 47 (33)
Family of farmer 76 (54)
Employee 19 (13)
Age (mean, range) 142 (36, range 6–79)
Age <18 years 30 (21)
Age 18–65 years 109 (77)
Age >65 years 3 (2)
Living on farm
Yes 113 (80)
No 29 (20)
Average number of hours
working on the farm per week
134 (mean 25, range 0–80)
0 42 (31)
1–20 27 (20)
>20 65 (49)
Frequency of pig contact 129
Daily 64 (50)
Weekly 25 (19)
Monthly 9 (7)
Less than monthly 31 (24)
Smoking 141
Yes 13 (9)
No 128 (91)
TABLE 3. Extended-spectrum β-lactamase (ESBL) genes in
pooled samples from pigs in different age groups
Age group Pooled samples, n
Pooled samples with ESBL
genes detected, n (%)
Sows 76 22 (29)
(Rearing) gilts 77 12 (16)
Suckling pigletsa 78 23 (29)
Weaned piglets 107 29 (27)
Finishing pigs 52 15 (29)
Total 390b 101 (26)
aSuckling piglets = pooled sample contained rectal swabs from one mother sow and
ﬁve of her suckling piglets.
bNo age group was reported for eight pools in one farm. On two farms, only nine
pools were analysed.
CMI Dohmen et al. ESBLs in pig farmers 919ResultsParticipant characteristics
In total, 142 people (47 farmers, 76 family members and 19
employees) living/working on 34 of the 40 farms (one to eleven
persons per farm) participated (Table 1). The response rate wasTABLE 2. Extended-spectrum β-lactamase (ESBL) genes in 157 pig
Pig isolates
Farm
Positive pooled
samples, n
ESBL type 1,
isolates (n)
ESBL type
isolates (n)
1 9/10 blaCTX-M-1 (16)
a
2 10/10 blaCTX-M-1 (16)
3 9/10 blaCTX-M-1 (13)
4 5/10 blaCTX-M-1 (7)
b
5 5/10 blaCTX-M-1 (7)
6 4/9 blaCTX-M-1 (4)
7 1/10 blaCTX-M-1 (2)
c
8 8/10 blaCTX-M-1 (11) blaTEM-52 (2)
9 8/10 blaCTX-M-1 (10) blaCTX-M-32 (
10 5/10 blaTEM-52 (9)
11 1/10 blaTEM-52 (2)
d
12 1/10 blaTEM-52 (1)
13 8/10 blaTEM-52 (13) blaCTX-M-1 (1
14 9/10 blaTEM-52 (6) blaCTX-M-2/97
15 6/10 blaCTX-M-14 (7)
16 1/10 blaCTX-M-14 (1)
17 8/10 blaCTX-M-14 (10) blaCTX-M-1 (1
18 9/10 blaCTX-M-15 (11)
19 0/10
aCTX-M-1 isolates were not tested for additional genes.
bSix isolates were Escherichia coli and one isolate was Escherichia sp.
cOne isolate was E. coli and one isolate was Salmonella sp.
dOne isolate was E. coli and one isolate was Escherichia fergusoni.
eFurther speciﬁcation by sequence analysis was unsuccessful.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology68%. The main reason for non-participation was the objection
to collect faecal samples.
Farm characteristics and pig isolates
On average, 470 sows were present per farm (range
110–1100). Finishing pigs were present on 27 of 40 farms.
Farms without ﬁnishing pigs either supplied pigs for ﬁnishing pig
farms (n = 11) or supplied gilts for other multiplier farms
(n = 2). On 23 farms gilts were supplied by another farm, the
other 17 farms had their own gilt supply (closed farms).
From 40 farms, 398 pooled samples (ten pooled samples per
farm, six rectal swabs each; on two farms, only nine pools were
analysed) taken from 2388 pigs were analysed. In total, 168 pig
isolates (114 pooled samples) from 23 farms were phenotypi-
cally conﬁrmed ESBL-PE (with combination disc test) (E. coli
(n = 160), Citrobacter freundii (n = 4), Enterobacter cloacaeand 12 human isolates
Human isolates
2, ESBL type 3,
isolates (n) Person
Gene type,
isolates (n)
3a blaCTX-M-1 (1)
5a blaCTX-M-1 (1)
5b blaCTX-M-1 (1)
1) 9a blaCTX-M-1 (1)
9b blaCTX-M-1 (1)
) blaTEM group 3 (1)
e 13a blaTEM-52 (2)
(4) blaCTX-M-1 (1)
15a blaCTX-M-14 (2)
)
19a blaCTX-M-1 (3)
and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 917–923
TABLE 4. Sequence types of Escherichia coli isolates and
plasmid characterization
Farm Origin Gene type E. coli ST Plasmid type
3 Human blaCTX-M-1 ST-540* IncI1
3 Pig blaCTX-M-1 ST-165
SLV*†,a IncI1
5 Human blaCTX-M-1 ST-453* IncI1
*
5 Human blaCTX-M-1 ST-453* IncI1
*
5 Pig blaCTX-M-1 ST-453* IncI1
5 Pig blaCTX-M-1 ST-453* IncI1
9 Human blaCTX-M-1 ST-711* IncI1
*
9 Human blaCTX-M-1 NT
†,b IncI1, NTRc
9 Pig blaCTX-M-1 ST-3321* IncI1
*
9 Pig blaCTX-M-1 ST-711 IncI1
13 Human blaTEM-52 ST-10 IncI1, NTR
13 Pig blaTEM-52 NT
†,d IncI1
15 Human blaCTX-M-14 ST-3079 ColIE2
15 Pig blaCTX-M-14 ST-744
SLV†,e ColIE2, NTR
*Data constructed from whole genome sequencing data [14]; †allele codes are
available as supportive information.
aSingle locus variant of ST-165.
bNew type, not registered yet.
cNo successful transformation.
dNew type, not registered yet. Not similar to other new type found.
eSingle locus variant of ST-744.
TABLE 5. Univariate and multivariate analyses for extended-
spectrum β-lactamase (ESBL) carriage in farmers, family
members and employees
Determinant
Univariate analysis Multivariate analysis
OR 95% CI p OR 95% CI p
Age 1.05 >1.00–1.09 0.01
per 10 years 1.7 1.1–2.5 0.01
Gender (male vs. female) 2.4 0.6–10.1 0.23
Smoking (yes vs. no) 1.3 0.1–12.2 0.80
Average number of hours
working on farm
per week
1.04 1.02–1.06 0.0001 1.04 1.02–1.06 0.0008
per 10 hours 1.5 1.2–1.8 0.0001 1.5 1.2–1.8 0.0008
Presence of ESBLs in pigs
(yes vs. no)
13.9 1.7–115.0 0.01 12.5 1.4–111.7 0.02
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Escherichia fergusoni (n = 1)). ESBL genes were detected in 157
isolates (107 pooled samples) from 18 farms (45%) (E. coli
(n = 154), Salmonella sp. (n = 1), Escherichia sp. (n = 1) and
E. fergusoni (n = 1)). Eleven phenotypically conﬁrmed ESBL-PE
isolates did not harbour one of the tested ESBL genes (E. coli
(n = 6), Citrobacter freundii (n = 4), Enterobacter cloacae (n = 1)).
blaCTX-M-1 was detected most frequently (12 farms, 89 isolates
(57%)), followed by blaTEM-52 (6 farms, 33 isolates (21%)) and
blaCTX-M-14 (3 farms, 18 isolates (11%)) (Table 2). ESBL gene
presence in pooled samples ranged from 16% in (rearing) gilts
to 29% in sows, suckling piglets and ﬁnishing pigs (Table 3).
Human isolates
From 142 humans, 16 isolates from 12 people were pheno-
typically conﬁrmed as ESBL-PE (E. coli (n = 13), C. freundii
(n = 1), Enterobacter cloacae (n = 1), and Proteus vulgaris (n = 1)).
ESBL genes were detected in 12 isolates (all E. coli) from eight
people (6%). blaCTX-M-1 was found in isolates from six partici-
pants, the other two participants carried blaTEM-52-positive and
blaCTX-M-14-positive isolates, respectively. Five out six humans
who carried blaCTX-M-1 were living/working on a farm where
blaCTX-M-1 was exclusively (n = 3) or predominantly (n = 2)
detected in pig isolates. The farmer who carried blaTEM-52
worked on a farm where blaTEM-52 was predominantly detected
in pig isolates and the farmer who carried blaCTX-M-14 worked
on a farm where blaCTX-M-14 was exclusively detected in pig
isolates (Table 2).
Prevalence of human ESBL carriage was 6% (95% CI 2–9%).
The prevalence among 64 individuals with daily pig contact was
11% (95% CI 3–19%) and among 52 individuals living/working
on a farm with ESBL-PE carrying pigs prevalence was 13% (95%Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectCI 4–23%). Prevalence was highest among 26 individuals with
daily pig contact on a farm where ESBL genes were detected in
pigs; 27% (95% CI 10–44%).
MLST and plasmid analyses
Bacterial strain typing by MLST and plasmid replicon typing
were performed on seven human isolates and seven pig isolates
from ﬁve farms (Table 4). Three sets of human and pig isolates
were identical in ST and plasmid type. For example in farm 5,
two human and two pig isolates were identiﬁed as E. coli ST-
453, harbouring blaCTX-M-1 on an IncI1 plasmid. In the
remaining four pairs, plasmid types but not STs were identical.
In three pairs, transformation did not succeed in one isolate.
Association between ESBL carriage in humans and pigs
ESBL carriage was detected in seven of 52 humans living/
working on farms where ESBL genes were detected in pigs and
in one of 90 humans living/working on farms where ESBL genes
were not detected in pigs (OR = 13.9, 95% CI 1.7–115.0, p
0.01) (Table 4). When this analysis was restricted to isolates
harbouring blaCTX-M-1, the association remained (OR = 17.9,
95% CI 1.9–168.2, p 0.01). As the prevalence is too low to
perform separate analyses for each gene type, no distinction in
ESBL gene types is made in further analyses. ESBL carriage in
humans was associated with average number of hours working
on the farm per week (OR = 1.04, 95% CI 1.02–1.06, p
0.0001), and age (OR = 1.05, 95% CI > 1.00 to 1.09, p 0.01). All
carriers (six farmers and two family members) reported to
work at least 20 hours per week on the farm. All seven carriers
that lived on a farm with ESBL-PE-carrying pigs reported to
have daily pig contact. No differences in prevalence could be
estimated for frequency of pig contact, living on farm, and being
a farmer, family member or employee because there was little
or no variation within the group of carriers. Results of uni-
variate analyses are presented in Table 5.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 917–923
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week, and presence of ESBLs in pigs were selected for multi-
variate analysis. Human carriage of ESBLs was positively asso-
ciated with average number of hours working on farm per week
(OR = 1.04, 95% CI 1.02–1.06, p 0.0008), and presence of
ESBLs in pigs (OR = 12.5, 95% CI 1.4–111.7, p 0.02). The ﬁnal
model is presented in Table 5.DiscussionAmong people working/living on pig farms, frequent contact
with pigs carrying ESBL-PE is associated with ESBL carriage.
Working hours on the farm (indicating direct contact with pigs)
and presence of ESBLs in pigs on the farm were associated with
human ESBL carriage. blaCTX-M-1 was found in six of eight
humans and 12 of 18 farms.
The overall prevalence for human ESBL carriage was 6%
(95% CI 2–9%), comparable to the reported prevalence of 5%
in a hospital patient population in the Netherlands [3], and to
ESBL carriage in people living in Dutch municipalities with high
or low broiler densities (3.6 and 6.7%, respectively) [9]. In the
current study, the prevalence was 13% (95% CI 4–23%)
among people living/working on a farm with ESBL-PE-carrying
pigs, and 27% (95% CI 10–44%) among humans with daily
exposure to ESBL-PE-carrying pigs. The latter is comparable
to the prevalence among 18 Dutch broiler farmers (33%)
working on farms where ESBL genes were detected in
broilers [8].
ESBL gene types detected in humans corresponded to those
exclusively or predominantly detected in pigs on the respective
farms. These results are suggestive for transmission of ESBL
genes from pigs to humans (or vice versa). The similarity in ST
and plasmid type between human and pig isolates found on two
farms strongly suggests the occurrence of clonal transmission.
This is endorsed by whole genome sequencing results; on farm
5, only six single nucleotide polymorphisms were found be-
tween one farmer isolate and two related pig isolates [14].
Results from other studies suggest that spread of ESBL genes in
E. coli between animals and farmers predominantly results from
horizontal dissemination of plasmids, rather than from trans-
mission of bacterial strains [7,8].
High use of antimicrobials in livestock production is
considered to be associated with a high prevalence of ESBL-PE
in animals [15]. Antimicrobial use in pigs on these farms is
comparable to the use in the Dutch pig farm population [16].
Faecal samples were collected through self-sampling and sent
to the laboratory by mail. As E. coli is known to survive in faeces
for a longer period without refrigeration, it is unlikely that this
led to under-detection of ESBL-PE [17,18].Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyAfter molecular analysis, ESBL genes were determined in
169/184 (92%) of the phenotypically determined ESBL-PE (both
human and pig isolates), which is in line with the positive pre-
dictive value of 93% for local ESBL conﬁrmation found in a
multi-centre evaluation study [19]. In the present study, most
Enterobacteriaceae other than E. coli with ESBL phenotype did
not harbour ESBL genes. In four of 15 isolates, the presence of
AmpC β-lactamases was conﬁrmed with the ESBL microarray
used (data not shown). Inducible chromosomal AmpC is often
present in Enterobacteriaceae other than E. coli and Klebsiella
pneumoniae and the presence of chromosomal or plasmid
mediated AmpC β-lactamases or other β-lactamases might
partially explain the discrepancy [19–23]. AmpC β-lactamases
were not further explored in this study. Isolates with PCR-
conﬁrmed blaCTX-M group 1 were not further analysed with
the ESBL-microarray. This may have resulted in under-
reporting of other ESBL genes present in the same isolate.
Yet, the likelihood of multiple different ESBL genes in a single
isolate is considered to be low [4].
Hospitalization and foreign travel are known risk factors for
human carriage of ESBLs [24,25]. None of the eight ESBL car-
riers had been hospitalized or had used antibiotics in the pre-
ceding 12 months. Five ESBL carriers had been abroad in the
preceding 12 months (France (n = 3), Scotland (n = 1), Turkey
(n = 1)), and travelling data were missing from three ESBL
carriers. ESBL-PEs have been reported widely in livestock and
meat [1–5,26], but they have also been found in healthy and
diseased companion animals [27,28], wildlife [29], vegetables
[30], drinking water [31] and sewage [30]. Duration of human
ESBL carriage can be prolonged [32,33], although determinants
inﬂuencing duration of carriage are not well understood. In the
current cross-sectional study, duration of ESBL carriage was
not determined, but a clear association between human ESBL
carriage and direct contact with ESBL-PE carrying pigs was seen.
Together with the increasing occurrence of ESBLs in livestock
worldwide, livestock farmers appear to have a higher risk of
carrying ESBLs than members of the general population. In this
study we did not observe human ESBL carriers without
frequent exposure to pigs. More research is needed on dura-
tion and risk of ESBL carriage. Moreover, the attributable role
of ESBL carriage in farmers for public health remains unclear
until more knowledge is gained on the transmission of ESBLs
from farmers into the community.ConclusionCarriage of ESBL in people working/living on pig farms is
associated with frequent contact with pigs carrying ESBL-PE. In
both humans and pigs, blaCTX-M-1 was the most frequentlyand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 917–923
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